GlassScriptPhysician profile
Scott D Geisler
NPI 1336147933
$86,537.65
in general payments reported to CMS, 2019-2025
50 companies · $25K in 2025
The $25K reported for 2025 was more than what 94% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $80.82 · 2021: $394 · 2022: $3,864 · 2023: $31K · 2024: $25K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $46K · Honoraria: $20K · Travel and Lodging: $8,387 · Food and Beverage: $4,458 · Long Term Medical Supply Or Device Loan: $2,864 · Education: $63.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,908.75 |
| Honoraria | $20,000.00 |
| Travel and Lodging | $8,386.57 |
| Food and Beverage | $4,457.64 |
| Long Term Medical Supply Or Device Loan | $2,863.58 |
| Education | $63.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $77,548.99 | 2021-2025 | Inspire |
| Philips North America LLC | $6,399.46 | 2019-2025 | (8269) Dreamstation Cpap, Full Face Masks - Over The Head, (Di5) Full Face Masks - Over The Head |
| Itamar Medical INC | $340.52 | 2022-2025 | Watchpatone |
| Zoll Respicardia, INC. | $242.28 | 2024 | Remede System |
| Abbvie INC. | $205.79 | 2021-2025 | |
| Resmed Corp | $153.25 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $127.62 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $90.04 | 2019-2025 | |
| Lundbeck LLC | $85.18 | 2020-2025 | Vyepti |
| Pfizer INC. | $80.60 | 2022-2024 | |
| Livanova USA, INC. | $79.06 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Biogen, INC. | $78.43 | 2019-2024 | Tysabri, Vumerity |
| Abbott Laboratories | $69.11 | 2023-2024 | Jot Dx, Infinity |
| Amgen INC. | $67.97 | 2019-2024 | Uplizna |
| Lilly USA, LLC | $58.51 | 2019-2024 | Kisunla, Amyvid, Reyvow |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Geisler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.